Proanthocyanidins Promote Endothelial Cell Viability and Angiogenesis

Area of Science:

• Biomaterials Science
• Cell Biology
• Pharmacology

Background:

• Botanic drugs are known to improve vascular circulation for ischemic conditions.
• Biomaterial research has largely overlooked botanic products for tissue regeneration.
• Understanding the effects of botanic compounds on endothelial cells is crucial for regenerative medicine.

Purpose of the Study:

• To investigate the effects of four botanic drugs on vascular endothelial cell growth.
• To identify specific botanic compounds with potential for promoting angiogenesis and tissue regeneration.
• To evaluate the efficacy of Proanthocyanidin (PAC) in stimulating endothelial cell activity.

Main Methods:

• Human umbilical endothelial cells (HUVECs) were cultured with varying doses of astragalus extract, astragalus injection, puerarin injection, and Proanthocyanidin (PAC).
• Cell viability and proliferation assays were performed under different serum conditions.
• The chick embryo chorioallantoic membrane model was used to assess angiogenicity.
• PAC was incorporated into polyvinyl alcohol cryogels to study its release and effect on HUVECs.

Main Results:

• Proanthocyanidin (PAC) demonstrated a potent, dose-dependent stimulation of HUVEC viability and proliferation.
• PAC maintained high cell viability even without growth factors and under low serum conditions.
• PAC incorporation into cryogels facilitated its release and subsequent stimulation of HUVEC proliferation.
• In vivo studies confirmed PAC's potent ability to stimulate vasculature development (angiogenesis).

Conclusions:

• Proanthocyanidin (PAC) effectively promotes endothelial cell activity and growth in vitro, independent of traditional growth factors.
• PAC can be successfully loaded into and released from biomaterial drug carriers.
• PAC exhibits significant potential for stimulating angiogenesis and can be applied in tissue regeneration strategies.